Pregnenolone

Pregnenolone is a steroid hormone precursor synthesized from cholesterol, often called the 'mother hormone' because it serves as the starting point for the production of DHEA, progesterone, cortisol, testosterone, and estrogen. It is foundational in hormone replacement and anti-aging protocols, supporting the full steroidogenic cascade.

Category
Hormonal Support
Demand
Moderate
Route
Oral capsule, sublingual, topical cream
FDA status
Available as supplement and compounded prescription; compounding eligibility varies by formulation
Also known as
PregP5

How Pregnenolone Works

Pregnenolone is synthesized from cholesterol via the enzyme CYP11A1 (P450scc) in mitochondria [3]. It serves as the universal precursor for all steroid hormones, converting to progesterone (via 3-beta-HSD), DHEA (via CYP17A1), and subsequently to cortisol, testosterone, and estradiol through downstream enzymatic pathways. As a neurosteroid, it also modulates GABA-A and NMDA receptors directly, supporting cognitive function independent of its hormonal conversion [2].

Clinical Evidence

Clinical studies show that pregnenolone levels decline approximately 60% between ages 35 and 75 [3]. Supplementation studies demonstrate improved cognitive performance and mood in individuals with low baseline levels [1]. The neurosteroid literature supports direct CNS effects via GABA and NMDA receptor modulation [2]. Evidence for downstream hormonal optimization is primarily from clinical practice rather than large RCTs.

Clinical Uses

  • Hormone precursor support in HRT protocols (foundational steroid synthesis)
  • Cognitive function and memory support (neurosteroid activity)
  • Adrenal fatigue and stress response protocols
  • Foundational hormone optimization before downstream hormone supplementation
  • Joint and inflammatory support (via downstream metabolites)

Patient Selection and Screening

Best candidates are patients with documented low serum pregnenolone, multiple downstream hormone deficiencies suggesting precursor insufficiency, or cognitive complaints concurrent with hormonal decline [1]. Patients with hormone-sensitive cancers, unpredictable steroid shunting toward cortisol under chronic stress, or those requiring precise hormonal control may be better served by targeted downstream hormone replacement [3].

Dosing and Administration

Begin at 10-25mg oral daily (micronized preferred for absorption) [1]. Recheck serum pregnenolone and downstream panel (progesterone, DHEA-S, cortisol, testosterone, estradiol) at 6-8 weeks. Titrate in 25mg increments, not exceeding 100mg daily without clear lab-based justification [3]. If conversion preferentially shunts to cortisol (elevated cortisol with minimal sex hormone improvement), consider adding targeted downstream hormones rather than increasing the pregnenolone dose further.

Route
Oral capsule, sublingual, topical cream
Protocol notes
Oral capsule (25-100mg daily) or sublingual/micronized formulations. Start at lower doses (10-25mg) and titrate based on serum levels and downstream hormone monitoring. Topical cream also available for transdermal delivery.

Safety and Monitoring

Potential side effects

  • Drowsiness or sedation (related to GABA-A receptor modulation at higher doses)
  • Acne or oily skin if conversion favors androgenic pathways
  • Mood changes (anxiety or agitation if cortisol conversion predominates)
  • Headache (typically mild, more common during initial titration)

Clinical considerations

  • Converts down multiple steroidogenic pathways; monitor downstream hormones (progesterone, DHEA, cortisol, testosterone, estradiol)
  • May preferentially convert to cortisol or progesterone depending on individual HPA axis stress load
  • Start low and titrate based on labs to avoid unpredictable pathway shunting
  • Contraindicated in hormone-sensitive cancers (can feed androgen or estrogen pathways)
  • Serum pregnenolone levels should be monitored to guide dosing

Practice Economics

Pregnenolone is an inexpensive foundational compound that anchors full HRT protocols [3]. While per-prescription revenue is modest, it strengthens patient relationships by demonstrating a systematic, upstream-first approach to hormone optimization. It drives downstream revenue when monitoring reveals the need for additional targeted interventions (progesterone, DHEA, testosterone) [1]. Practices offering full steroid panels and pregnenolone together create a differentiated, evidence-based service model.

FDA Category Status

Available as supplement and compounded prescription; compounding eligibility varies by formulation

FDA bulk drug substance category determines compounding eligibility. Category designations are subject to change; always verify current status before prescribing.

Frequently Asked Questions

Why is pregnenolone called the 'mother hormone' and why does that matter clinically?

Pregnenolone sits at the top of the steroidogenic pathway, converting into progesterone, DHEA, cortisol, testosterone, and estrogen through various enzymatic steps. Supplementing pregnenolone supports the entire hormonal cascade, allowing the body to direct conversion based on need. This makes it a foundational intervention before adding specific downstream hormones, though the conversion is not always predictable.

How do you determine whether a patient needs pregnenolone vs specific hormones?

Test pregnenolone levels alongside a full steroid hormone panel. Low pregnenolone with multiple downstream hormone deficiencies suggests a precursor deficit where pregnenolone supplementation may broadly improve the cascade. If pregnenolone is normal but specific downstream hormones are low, the issue is enzymatic conversion or end-organ, and targeted hormone replacement is more appropriate.

What monitoring is needed for patients on pregnenolone?

Monitor serum pregnenolone, progesterone, DHEA-S, cortisol (AM), total and free testosterone, and estradiol at baseline and every 6-8 weeks during titration. Pay attention to which pathway predominates (cortisol vs sex hormones vs progesterone) as this guides whether to continue pregnenolone alone or add targeted downstream interventions.

References

  1. Marx et al. - Pregnenolone as a neurosteroid: cognitive and mood effects (2009)
  2. Vallee et al. - Neurosteroids: deficient cognitive performance in aged rats depends on pregnenolone sulfate levels (1997)
  3. Baulieu - Neurosteroids: a novel function of the brain (1998)

Disclaimer: This information is intended for licensed healthcare providers only and does not constitute medical, legal, or regulatory advice. Clinical decisions should be based on your professional judgment, current evidence, and applicable regulations. Always verify FDA category status and compounding eligibility before prescribing.

Launch a Peptide Program With Karpa

Karpa handles intake, licensed prescribing, and direct-to-patient pharmacy fulfillment across all 50 states. No medical license required.

Explore peptide programs